118 related articles for article (PubMed ID: 37315647)
1. Bioinformatics analysis and in vivo validation study of Ophiocordyceps sinensis (Berk.)G.H.Sungetal against lung adenocarcinoma.
Zhang X; Wang M; Liang X; Wang J; Zhang M; Li C; Wei L; Bi H
J Ethnopharmacol; 2023 Dec; 317():116739. PubMed ID: 37315647
[TBL] [Abstract][Full Text] [Related]
2. Molecular and metabolic mechanisms of bufalin against lung adenocarcinoma: New and comprehensive evidences from network pharmacology, metabolomics and molecular biology experiment.
Shi S; Zhao S; Tian X; Liu F; Lu X; Zang H; Li F; Xiang L; Li L; Jiang S
Comput Biol Med; 2023 May; 157():106777. PubMed ID: 36924737
[TBL] [Abstract][Full Text] [Related]
3. Integrating Network Pharmacology, Molecular Docking, and Experimental Validation to Investigate the Mechanism of (-)-Guaiol Against Lung Adenocarcinoma.
Zeng Y; Pan Y; Zhang B; Luo Y; Tian J; Wang Y; Ju X; Wu J; Li Y
Med Sci Monit; 2022 Jul; 28():e937131. PubMed ID: 35871777
[TBL] [Abstract][Full Text] [Related]
4. Network Pharmacology and Bioinformatics Analysis Identifies Potential Therapeutic Targets of Paxlovid Against LUAD/COVID-19.
Zhang W; Yang Z; Zhou F; Wei Y; Ma X
Front Endocrinol (Lausanne); 2022; 13():935906. PubMed ID: 36157452
[TBL] [Abstract][Full Text] [Related]
5. Identifying the Antitumor Effects of Curcumin on Lung Adenocarcinoma Using Comprehensive Bioinformatics Analysis.
Yang FR; Li SY; Hu XW; Li XR; Li HJ
Drug Des Devel Ther; 2022; 16():2365-2382. PubMed ID: 35910781
[TBL] [Abstract][Full Text] [Related]
6. Exploring the potential mechanism of emetine against coronavirus disease 2019 combined with lung adenocarcinoma: bioinformatics and molecular simulation analyses.
Zhang K; Wang K; Zhang C; Teng X; Li D; Chen M
BMC Cancer; 2022 Jun; 22(1):687. PubMed ID: 35733175
[TBL] [Abstract][Full Text] [Related]
7. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
8. Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma.
Zhao XY; Yang YY; Feng JL; Feng CL
J Vis Exp; 2023 Mar; (193):. PubMed ID: 36939253
[TBL] [Abstract][Full Text] [Related]
9. Uncovering anti-influenza mechanism of Ophiocordyceps sinensis using network pharmacology, molecular pharmacology, and metabolomics.
Zhou J; Wang M; Sun T; Zhou X; Wang J; Wang Y; Zhang R; Luo R; Yu H
Medicine (Baltimore); 2023 Sep; 102(35):e34843. PubMed ID: 37657041
[TBL] [Abstract][Full Text] [Related]
10. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma.
Wu Q; Wang YB; Che XW; Wang H; Wang W
J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006
[TBL] [Abstract][Full Text] [Related]
11. [Effect of "Hedyotis Diffusae Herba-Smilacis Glabrae Rhizoma" in treatment of lung adenocarcinoma based on network pharmacology].
Li JL; Hou W
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(23):6261-6270. PubMed ID: 34951253
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
13. The identification of key biomarkers in patients with lung adenocarcinoma based on bioinformatics.
Ni KW; Sun GZ
Math Biosci Eng; 2019 Aug; 16(6):7671-7687. PubMed ID: 31698633
[TBL] [Abstract][Full Text] [Related]
14. Network Pharmacology and Experimental Verification to Explore the Potential Mechanism of Yin-Huo-Tang for Lung Adenocarcinoma Recurrence.
Liu D; Lin S; Li Y; Zhou T; Hu K; Li Q
Drug Des Devel Ther; 2022; 16():375-395. PubMed ID: 35210754
[TBL] [Abstract][Full Text] [Related]
15. The Effect of GLUT1 on the Survival Rate and Immune Cell Infiltration of Lung Adenocarcinoma and Squamous Cell Carcinoma: A Meta and Bioinformatics Analysis.
Zhang G; Dong R; Kong D; Liu B; Zha Y; Luo M
Anticancer Agents Med Chem; 2022; 22(2):223-238. PubMed ID: 34238200
[TBL] [Abstract][Full Text] [Related]
16. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
17. Predicting potential therapeutic targets and small molecule drugs for early-stage lung adenocarcinoma.
Yu Y; Li L; Luo B; Chen D; Yin C; Jian C; You Q; Wang J; Fang L; Cai D; Sun J
Biomed Pharmacother; 2024 May; 174():116528. PubMed ID: 38555814
[TBL] [Abstract][Full Text] [Related]
18. Exploring the mechanisms of action of
Zhang X; Wang M; Qiao Y; Shan Z; Yang M; Li G; Xiao Y; Wei L; Bi H; Gao T
Ann Transl Med; 2022 Mar; 10(6):282. PubMed ID: 35434037
[TBL] [Abstract][Full Text] [Related]
19. Comparison of tumor related signaling pathways with known compounds to determine potential agents for lung adenocarcinoma.
Xu S; Liu R; Da Y
Thorac Cancer; 2018 Aug; 9(8):974-988. PubMed ID: 29870138
[TBL] [Abstract][Full Text] [Related]
20. Integrated bioinformatics analysis reveals CDK1 and PLK1 as potential therapeutic targets of lung adenocarcinoma.
Li S; Li H; Cao Y; Geng H; Ren F; Li K; Dai C; Li N
Medicine (Baltimore); 2021 Aug; 100(32):e26474. PubMed ID: 34397869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]